Inspire Medical CFO reports 19,794-share holding

Inspire Medical Systems, Inc. chief financial officer Matthew J. Osberg has filed an initial ownership report showing his equity stake in the company.

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. chief financial officer Matthew J. Osberg has filed an initial ownership report showing his equity stake in the company. The Form 3 lists direct ownership of 19,794 shares of common stock. A noted portion represents restricted stock units that vest in three equal annual installments starting on January 31, 2027, with each unit convertable into one share of common stock if he remains employed through the vesting dates.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Osberg Matthew J

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 19,794 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on January 31, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Matthew Osberg’s Form 3 for Inspire Medical Systems (INSP) report?

The Form 3 reports that CFO Matthew J. Osberg beneficially owns 19,794 shares of Inspire Medical Systems common stock. This includes restricted stock units that may settle into shares if future vesting conditions tied to continued employment are satisfied.

How many Inspire Medical Systems (INSP) shares does the CFO report holding?

CFO Matthew J. Osberg reports beneficial ownership of 19,794 shares of Inspire Medical Systems common stock. This figure reflects his direct holdings, including equity that is subject to vesting conditions described in the filing’s restricted stock unit footnote.

What are the vesting terms of the RSUs reported by the Inspire Medical Systems CFO?

The RSUs vest in three equal annual installments beginning January 31, 2027. Each restricted stock unit gives a contingent right to receive one share of Inspire Medical Systems common stock, conditioned on Mr. Osberg’s continuous employment through each relevant vesting date.

Does Matthew Osberg’s Form 3 indicate open-market buying or selling of INSP shares?

The Form 3 is primarily an initial ownership report and does not specify open-market purchases or sales. It discloses total beneficial ownership of 19,794 shares and explains that part of this position relates to time-vested restricted stock units granted by the company.

What does a Form 3 filing mean for Inspire Medical Systems (INSP) insiders?

A Form 3 is the initial statement of beneficial ownership that insiders, such as officers and directors, must file. For Inspire Medical Systems, it formally records CFO Matthew Osberg’s 19,794-share stake and the structure of his restricted stock units at the time he became a reporting insider.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 06:53 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Osberg Matthew J

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/17/2026

3. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,794(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on January 31, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Matthew J. Osberg	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.